Overview Financials News + Filings Key Docs Charts Transactions Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Credit agrmnt [a]
Appointed director
Monthly oper. report
|
|
ACCENTIA BIOPHARMACEUTICALS INC (ABPI)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/18/2008 |
8-K
| Credit agreement amendment|
Docs:
|
"Securities Purchase Agreement, among Accentia Biopharmaceuticals, Inc. (“Accentia”) and each of the purchasers of the Private Placement",
"Registration Rights Agreement, among Accentia and each of the purchasers of the Private Placement",
"8% Original Issue Discount Secured Convertible Debenture, among Accentia and each of the purchasers of the Private Placement",
"Security Agreement, among Accentia and its subsidiaries, Accentia Specialty Pharmacy, Inc. and AccentRX, Inc. and each of the purchasers of the Private Placement",
"Common Stock Purchase Warrant",
"Subsidiary Guarantee among Accentia Specialty Pharmacy, Inc. and AccentRX, Inc. and each of the purchasers of the Private Placement",
"Third Amendment to Revolving Credit Agreement dated June 17, 2008, among Southwest Bank of St. Louis (“Southwest”) and Accentia",
"Revolving Credit Note Modification Agreement dated June 17, 2008, among Southwest and Accentia",
"Stock Pledge Agreement dated June 17, 2008, among Southwest and Accentia",
"Reaffirmation of Guaranty dated June 17, 2008, among Southwest and Accentia",
"Amendment No. 1 to Termination Agreement Re Biologics Distribution Agreement dated June 17, 2008, among McKesson Corporation (“McKesson”) and Accentia",
"Securities Purchase Agreement, among Accentia Biopharmaceuticals, Inc. (“Accentia”) and each of the purchasers of the Private Placement",
"Accentia Biopharmaceuticals Announces $8.5 Million Financing to Advance Key Strategies for SinuNase™ and Revimmune™" |
|
|
|